title: Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
abstract: We have characterized the interaction between apolipoprotein E (apoE) and amyloid beta peptide (Abeta) in the soluble fraction of the cerebral cortex of Alzheimer's disease (AD) and control subjects. Western blot analysis with specific antibodies identified in both groups a complex composed of the full-length apoE and Abeta peptides ending at residues 40 and 42. The apoE-Abeta soluble aggregate is less stable in AD brains than in controls, when treated with the anionic detergent SDS. The complex is present in significantly higher quantity in control than in AD brains, whereas in the insoluble fraction an inverse correlation has previously been reported. Moreover, in the AD subjects the Abeta bound to apoE is more sensitive to protease digestion than is the unbound Abeta. Taken together, our results indicate that in normal brains apoE efficiently binds and sequesters Abeta, preventing its aggregation. In AD, the impaired apoE-Abeta binding leads to the critical accumulation of Abeta, facilitating plaque formation.
authors.affiliation: Division Of Neuropathology, Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, 44106 Cleveland, OH 44106, USA.
authors.forename: C
authors.initials: C
authors.lastname: Russo
authors.forename: G
authors.initials: G
authors.lastname: Angelini
authors.forename: D
authors.initials: D
authors.lastname: Dapino
authors.forename: A
authors.initials: A
authors.lastname: Piccini
authors.forename: G
authors.initials: G
authors.lastname: Piombo
authors.forename: G
authors.initials: G
authors.lastname: Schettini
authors.forename: S
authors.initials: S
authors.lastname: Chen
authors.forename: J K
authors.initials: JK
authors.lastname: Teller
authors.forename: D
authors.initials: D
authors.lastname: Zaccheo
authors.forename: P
authors.initials: P
authors.lastname: Gambetti
authors.forename: M
authors.initials: M
authors.lastname: Tabaton
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000302:isolation & purification / Q000378:metabolism*; D000911:Antibodies, Monoclonal; D001057:Apolipoproteins E / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D015153:Blotting, Western; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology; D000939:Epitopes / Q000032:analysis; D005838:Genotype; D006801:Humans; D012016:Reference Values; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D016229:Amyloid beta-Peptides; D000911:Antibodies, Monoclonal; D001057:Apolipoproteins E; D000939:Epitopes